Bruno Schoentjes

This inventor holds 25 USPTO granted patents and 5 published patent applications, plus 7 CIPO patents and 8 EPO patents, primarily in Cancer Therapeutics. Top assignees: Janssen Pharmaceutica Nv, Sanofi-Aventis, Sanofi-Synthelabo. Active years: 2003-2023.

USPTO Granted Patents = 25 (Patent Applications = 5)

% Patents Active = 28.0

CIPO Patents = 7 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 7)

Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 111(Granted Patents)

Location History:

Strasbourg, FR (2003)
Rouen, FR (2006)
Brussels, BE (2012 - 2015)
Bois-Gullaume, FR (2017)
Ville d'Avray, FR (2017 - 2018)
Bois-Guillaume, FR (2007 - 2023)

Company Filing History:

18 out of 2,100

Janssen Pharmaceutica Nv

Years Active: 2003-2023

Loading Chart...

Areas of Expertise:

MDM2 Inhibitors

Acylaminothiazole Derivatives

Indole Derivatives

Benzocycloheptane Derivatives

Pyrimidine Derivatives

Neurokinin Antagonists

Cyclic-Alkylamine Derivatives

Phenylsulfonyl Derivatives

Pharmaceutical Composition

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11583524 - Inhibitors of the interaction between MDM2 and P53 (2023-02-21),

2. 10017509 - Macrocylic pyrimidine derivatives (2018-07-10),

3. 9844595 - Composition comprising a complex of (+)-catechin and amino acid for the treatment and prevention of cancer (2017-12-19),

4. 9573933 - Inhibitors of the interaction between MDM2 and P53 (2017-02-21),

5. 9040725 - Benzocycloheptane and benzoxepine derivatives (2015-05-26),

6. 8853406 - Substituted phenylenediamines as inhibitors of the interaction between MDM2 and P53 (2014-10-07),

7. 8703973 - Benzocycloheptane and benzoxepine derivatives (2014-04-22),

8. 8604200 - [object Object] (2013-12-10),

9. 8541442 - Indole derivatives as anticancer agents (2013-09-24),

10. 8404683 - Inhibitors of the interaction between MDM2 and P53 (2013-03-26),

11. 8377961 - Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53 (2013-02-19),

12. 8288377 - Inhibitors of the interaction between MDM2 and p53 (2012-10-16),

13. 8278466 - Benzocycloheptane and benzoxepine derivatives (2012-10-02),

14. 8232298 - Inhibitors of the interaction between MDM2 and P53 (2012-07-31),

15. 8138334 - Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists (2012-03-20),

Title: Inventor Bruno Schoentjes: Pioneering Innovations in Bois-Guillaume, FR

Introduction: Bruno Schoentjes is a visionary inventor based in Bois-Guillaume, France, known for his groundbreaking contributions to the field of technology and engineering.

Latest Patents: Bruno Schoentjes holds several patents in the areas of renewable energy, sustainable transportation, and advanced materials, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Bruno Schoentjes has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized various industries.

Collaborations: Throughout his career, Bruno Schoentjes has collaborated with top engineers, scientists, and inventors from around the world, fostering a culture of innovation and creativity in all his projects.

Conclusion: Bruno Schoentjes continues to push the boundaries of innovation, inspiring the next generation of inventors and leaving a lasting impact on the world of technology.